Recent News

• 02.10.2026 - Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2026 Financial Results
• 02.10.2026 - 10-Q - Quarterly report [Sections 13 or 15(d)]
• 01.28.2026 - Sonoma Pharmaceuticals Welcomes New Member of its Board of Directors and New Senior Vice President of Regulatory, Quality and Product Development
• 11.13.2025 - National Rosacea Society Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced
• 11.06.2025 - Sonoma Pharmaceuticals to Exhibit at MEDICA 2025 in Düsseldorf
• 11.04.2025 - Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2026 Financial Results
• 11.04.2025 - 10-Q - Quarterly report [Sections 13 or 15(d)]

Recent Filings

• 02.10.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 02.09.2026 - 3 Initial statement of beneficial ownership of securities
• 01.28.2026 - 8-K Current report
• 01.12.2026 - EX-99.1 EX-99.1
• 01.12.2026 - 8-K Current report
• 01.02.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.02.2026 - 8-K Current report
• 01.02.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.02.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.02.2026 - 4 Statement of changes in beneficial ownership of securities